Home » Topics » BioWorld Science

BioWorld Science
RSS

Synairgen reports interim data from phase II trial of SNG-001 in COPD

June 22, 2018

Phase II/III trial of NBTXR-3 in soft tissue sarcoma meets primary endpoint

June 22, 2018

FDA accepts sBLA for Opdivo plus low-dose Yervoy for first-line NSCLC

June 22, 2018

Revance initiates phase III program with RT-002 injectable for cervical dystonia

June 22, 2018

Attenuated vaccine candidate shows rapid probiotic-like protection from cholera in animal models

June 22, 2018

Ironwood initiates phase III trials of IW-3718 in persistent GERD

June 22, 2018

ACKR3 gene copy number variations linked to pregnancy loss

June 22, 2018

Alpha Biopharma closes series A financing for phase II study of AZD-3759

June 22, 2018

FDA grants regenerative medicine advanced therapy designation for VY-AADC

June 22, 2018

Statins improve venetoclax anticancer activity in hematologic malignancies

June 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...